Measuring informed consent capacity in an Alzheimer's disease clinical trial

INTRODUCTION: Accurately and efficiently determining a participant's capacity to consent to research is critically important to protect the rights of patients with Alzheimer's disease (AD). METHODS: Understanding of the informed consent document was assessed in 613 community-dwelling patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Guarino, Peter D., Vertrees, Julia E., Asthana, Sanjay, Sano, Mary, Llorente, Maria D., Pallaki, Muralidhar, Love, Susan, Schellenberg, Gerard D., Dysken, Maurice W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2016
Materias:
Featured Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5651363/
https://www.ncbi.nlm.nih.gov/pubmed/29067313
http://dx.doi.org/10.1016/j.trci.2016.09.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5651363/
https://www.ncbi.nlm.nih.gov/pubmed/29067313
http://dx.doi.org/10.1016/j.trci.2016.09.001

Ejemplares similares